Article
Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.
International journal of cancer - 1 Oct 2022
Desai Kanan T, Adepiti Clement A, Schiffman Mark, Egemen Didem, Gage Julia C, Wentzensen Nicolas, de Sanjose Silvia, Burk Robert D, Ajenifuja Kayode O
Abstract excerpt
Accelerated cervical cancer control will require widespread human papillomavirus (HPV) vaccination and screening. For screening, sensitive HPV testing with an option of self-collection is increasingly desirable. HPV typing predicts risk of precancer/cancer, which could be useful in management, but most current typing assays are expensive and/or complicated. An existing 15-type isothermal amplification assay...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
